UBS Raises Estimates and Price Target on Teradyne (TER); LitePoint Gains Driving Huge N-T Results

July 27, 2012 3:41 PM EDT Send to a Friend
Get Alerts TER Hot Sheet
Price: $17.05 -1.33%

Rating Summary:
    10 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade TER Now!
UBS maintains a 'Neutral' on Teradyne (NYSE: TER) price target of $16.00 (from $15.00).

Analyst, Stephen Chin, said, "Teradyne's 2Q12 results were well above its guidance as its sales and orders of LitePoint products were $112M and $189M, well above our estimates of $31M and $55M. Teradyne now estimates Litepoint sales in 2012-2013 will be $450M (earlier targeted 2012-13 only at $350M) which we believe could be conservative as Litepoint’s cellular test business sales (small % in 2Q12) likely ramp in 2013." (UBS raises FY13 EPS estimate to $2.00)

For an analyst ratings summary and ratings history on Teradyne click here. For more ratings news on Teradyne click here.

Shares of Teradyne closed at $14.85 yesterday, with a 52 week range of $10.37-$18.01.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

UBS

Add Your Comment